• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Inhaled Corticosteroid Device Companies

    ID: MRFR/HC/4953-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Inhaled corticosteroids (ICS) are medications commonly used for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These medications are delivered using inhalation devices to ensure targeted and effective treatment of the airways. Several companies are involved in the development and production of inhaled corticosteroid devices.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Inhaled Corticosteroid Device Market Research Report-Forecast to 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Inhaled Corticosteroid Device Market

    Inhaler Corticosteroid Device Companies

     


    Latest Inhaler Corticosteroid Device Companies Update:

    GlaxoSmithKline (GSK) and Innoviva's Trelegy Ellipta Approved for Chronic Obstructive Pulmonary Disease (COPD): This September 2023 milestone expands Trelegy Ellipta's reach  beyond asthma into COPD, a major market segment, potentially boosting GSK's market share


    Teva Pharmaceuticals Launches Generic Version of AstraZeneca's Symbicort: This December 2023 development introduces a more affordable option for Symbicort, potentially increasing access to treatment for patients and impacting market dynamics.


    Aptar Pharma & Tech Partners with Chiesi for Next-Generation Nebulizers: This January 2024 collaboration leverages Aptar's expertise in device design with Chiesi's respiratory medications, aiming to develop user-friendly and efficient nebulizers.


    List of Inhaler Corticosteroid Device Key companies in the market

    • Plumage Therapeutics LLP

    • Pearl Therapeutic Inc

    • Teijin LTD, Glaxo’s Advair

    • LIYEN, Inc

    • Amgen Inc

    • Kos Pharmaceutical, Inc

    • Teva Pharmaceutical.